Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
29th Dec 17 Source: Company
- €3.3 billion turnover
-
-€135 million
profit - 4,089 employees
-
30th Sep 16 Source: CRO
- €3.1 billion turnover
-
€276.9 million
profit - 5,112 employees
- 1 more year available »
Ranking
By Turnover
(€3.3 billion)- 30th in Top Companies
By Employees
(4,089)- 43rd in Top Companies
- 4,089
- €3.3 billion
Employees
- David Keenan Vice President}
Latest News
- 12:30am Meat consumption must drop by 90% to avert climate crisis, report warns
- 12:22am JobPath scheme a dead end for unemployed, claim experts
- Jan 16 Judge prevents receivers taking possession of Kilmacthomas Workhouse
- Jan 16 Dublin Airport seeks contractors for €1bn worth of work
- Jan 16 $18.5m fundraise for cybersecurity group with Irish founder